Lataa...
3D printing for drug manufacturing: A perspective on the future of pharmaceuticals
Since a three-dimensional (3D) printed drug was first approved by the Food and Drug Administration in 2015, there has been a growing interest in 3D printing for drug manufacturing. There are multiple 3D printing methods – including selective laser sintering, binder deposition, stereolithography, ink...
Tallennettuna:
| Julkaisussa: | Int J Bioprint |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Whioce Publishing Pte. Ltd.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7582011/ https://ncbi.nlm.nih.gov/pubmed/33102905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18063/IJB.v4i1.119 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|